Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies.
Safety and effectiveness assessment of intravenous immunoglobulin in the treatment of relapsing-remitting multiple sclerosis: A meta-analysis.
Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS.
Re: The effect of venous anatomy on the morphology of multiple sclerosis lesions: a susceptibility-weighted imaging study.
Delayed iron deposit and atrophy of the putamen in a case with osmotic demyelination syndrome.
No evidence for increased brain iron deposition in patients with ischemic white matter disease.
Nrf2-dysregulation correlates with reduced synthesis and low glutathione levels in experimental autoimmune encephalomyelitis.
Physical comorbidities increase the risk of psychiatric comorbidity in multiple sclerosis.
MicroRNAs associated with the pathogenesis of multiple sclerosis.
Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS).
Clinical Profiles and Short-Term Outcomes of Acute Disseminated Encephalomyelitis in Adult Chinese Patients.
Neuromyelitis optica and pregnancy.
Normal-appearing brain tissue analysis in radiologically isolated syndrome using 3 T MRI.
Treatment of ongoing autoimmune encephalomyelitis with activated B-cell progenitors maturing into regulatory B cells.
Programmed cell death and natural killer cells in multiple sclerosis: new potential therapeutic targets?
Targeting Non-classical Myelin Epitopes to Treat Experimental Autoimmune Encephalomyelitis.
Oxidative damage and chemokine production dominate days before immune cell infiltration and EAE disease debut.
Autophagy Is Involved in the Sevoflurane Anesthesia-Induced Cognitive Dysfunction of Aged Rats.
Association Between Intellectual Capacity And Fatigue In Persons With Multiple Sclerosis: 1292 Board #4 June 2, 8: 00 AM - 10: 00 AM.
Myelinating glia differentiation is regulated by extracellular matrix elasticity.
Striving for Balance Between Caring and Restraint: Young Adults' Experiences with Parental Multiple Sclerosis.
Safety and efficacy of amiselimod in relapsing multiple sclerosis (MOMENTUM): a randomised, double-blind, placebo-controlled phase 2 trial.
Finding NMO: The Evolving Diagnostic Criteria of Neuromyelitis Optica.
An investigation of commonly prescribed stretches of the ankle plantarflexors in people with Multiple Sclerosis.
Acute visual loss after ipilimumab treatment for metastatic melanoma.
Pages
« first
‹ previous
…
803
804
805
806
807
808
809
810
811
…
next ›
last »